Jeffrey Farrow

Insider Reports History

Entity
Individual
Location
Two Corporate Drive, South San Francisco, CA
Signature
/s/ Jeffrey Farrow, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Farrow:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. Chief Financial Officer and Chief Strategy Officer Restricted Stock Units 83.6K $2.56M $30.60 Jun 17, 2024 Direct
Tarsus Pharmaceuticals, Inc. Chief Financial Officer and Chief Strategy Officer Stock Option (right to buy) 47.5K $1.8M $10.99 Mar 7, 2024 Direct
Tarsus Pharmaceuticals, Inc. Chief Financial Officer and Chief Strategy Officer Common Stock 18.1K $498K $27.47 Jun 18, 2024 Direct
Global Blood Therapeutics, Inc. Chief Financial Officer Common Stock 0 $46.99 Oct 5, 2022 Direct
Global Blood Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 0 Oct 5, 2022 Direct
Global Blood Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 0 Oct 5, 2022 Direct

Insider Reports Filed by Jeffrey Farrow

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TARS Tarsus Pharmaceuticals, Inc. Jun 17, 2024 3 -$287K 4 Jun 20, 2024 Chief Financial Officer and Chief Strategy Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 7, 2024 2 $0 4 Mar 11, 2024 Chief Financial Officer and Chief Strategy Officer
TARS Tarsus Pharmaceuticals, Inc. Apr 24, 2023 0 $0 3/A Apr 28, 2023 Chief Financial Officer and Chief Strategy Officer Exhibit 24 - Power of Attorney
TARS Tarsus Pharmaceuticals, Inc. Apr 24, 2023 2 $0 4 Apr 26, 2023 Chief Financial Officer and Chief Strategic Officer
GBT Global Blood Therapeutics, Inc. Oct 5, 2022 14 $0 4 Oct 6, 2022 Chief Financial Officer
GBT Global Blood Therapeutics, Inc. Sep 27, 2022 2 $388K 4 Sep 29, 2022 Chief Financial Officer
GBT Global Blood Therapeutics, Inc. Sep 1, 2022 6 -$2.27M 4 Sep 6, 2022 Chief Financial Officer
GBT Global Blood Therapeutics, Inc. Aug 1, 2022 4 -$68.9K 4 Aug 3, 2022 Chief Financial Officer
GBT Global Blood Therapeutics, Inc. Mar 1, 2022 6 -$39.3K 4 Mar 3, 2022 Chief Financial Officer
GBT Global Blood Therapeutics, Inc. Feb 1, 2022 5 -$132K 4 Feb 3, 2022 Chief Financial Officer
GBT Global Blood Therapeutics, Inc. Sep 1, 2021 3 -$40.9K 4 Sep 3, 2021 Chief Financial Officer
GBT Global Blood Therapeutics, Inc. Aug 1, 2021 5 -$119K 4/A Sep 24, 2021 Chief Financial Officer